European Commission concludes Novavax talks for COVID-19 vaccine
The European Commission has concluded its talks with pharmaceutical company Novavax regarding the purchase of its potential COVID-19 vaccine.
The European Commission and Novavax envisaged...
Renewed collaboration to eliminate tropical diseases
A decades-long collaboration between the World Health Organization (WHO) and Sanofi has been renewed in order to sustain efforts to eliminate neglected tropical diseases.
The...
Clinical trials for another COVID-19 vaccine begin in UK
Early Phase I and Phase II clinical trials have started in the UK for the Valneva COVID-19 vaccine, which is to be tested on...
Pritelivir Phase III clinical trials for HSV immunocompromised patients
The medicine Pritelivir is to enter Phase III clinical trials for the treatment of immunocompromised patients who have acyclovir-resistant mucocutaneous herpes simplex virus (HSV)...
AstraZeneca to test component of Russia’s Sputnik V vaccine
AstraZeneca will be testing a component of Russia’s Sputnik V COVID-19 vaccine in clinical trials of its own vaccine against the virus.
Following the preliminary...
Chemotherapy-free treatment for Chronic Lymphocytic Leukaemia patients
For the first time, patients in Scotland with previously untreated Chronic Lymphocytic Leukaemia will be able to access chemotherapy-free treatment.
The Scottish Medicines Consortium has...
COVID-19 Oxford vaccine found safe and effective in Phase III trial
The first full results from the Phase III Oxford COVID-19 vaccine have found it to be safe and effective to protect against the virus.
The...
First ever patient to receive COVID-19 vaccination in the UK
Today marks a landmark moment for the United Kingdom as the first NHS patient has received the Pfizer/BioNTech COVID-19 vaccine.
The biggest vaccination campaign in...
Meningococcus B vaccine shows 79% effectiveness
A vaccine for the deadly Meningococcus B has been shown to have 79% effectiveness in patients under the age of 18.
Meningococcus group B is...
COVID-19 vaccine added to damages scheme in case of severe disability
The UK has taken the precautionary measure of adding COVID-19 to its Vaccine Damage Payments Scheme so people will be able to access financial...
Clinical trial investigates COVID-19 protection for health professionals
Healthcare professionals in the UK will be taking part in a clinical trial to test the efficacy of Carragelose nasal spray for COVID-19 protection.
To...
Pfizer-BioNTech COVID-19 vaccine authorised by UK Government
The UK Government has authorised the Pfizer-BioNTech COVID-19 vaccine which will be made available from next week.
The UK Government has granted a temporary authorisation...
UK medicine manufacturing to receive funding boost
Funding of £20m will be provided to improve medicine supply chains in the UK and help to create thousands of new jobs.
The money, which...
Establishing a Pharmaceutical Strategy for Europe
The European Commission has adopted a Pharmaceutical Strategy for Europe which aims to ensure access to medicines and support innovation and sustainability in the...
European Commission approves contract for potential COVID-19 vaccine
The European Commission has approved a contract with Moderna to secure access to a potential COVID-19 vaccine.
The contract will be the sixth one made...
Clinical trial explores psychedelic treatments for PTSD in veterans
A company exploring the efficacy of psychedelic treatments for PTSD in veterans has announced the international expansion of its Phase 2A clinical trials.
The Mydecine...
Dealing with antimicrobial resistance during COVID-19
To coincide with Antimicrobial Awareness Week 2020, a new report of case studies has been published that gives a platform to people living with...
Nasal spray clinical trial to investigate prevention of COVID-19 infection
A randomised, double blind trial will be testing the efficacy of a nasal spray to protect frontline healthcare workers against COVID-19.
The spray is the...
Oxford COVID-19 vaccine shows promising results in older adults
Phase II of the Oxford vaccine trial has shown promising safety results in older adults, finding it provokes an immune response.
The early stage results,...
European Commission approves epilepsy medicine to treat children
The European Commission has approved expanding the indication of anti-epileptic agent Fycompa to include the treatment of children with epilepsy.
The European Commission (EC) has...
